We observed a protective effect of higher RPL28 expression on overall CRC risk in TCM cells at rest (OR = 0.92, CI = 0.89 to 0.96) and CD4 naïve cells 5 days post activation (OR = 0.89, CI = 0.82 to 0.96). This evidence concerns the gene RPL28 and colorectal carcinoma.